Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
5
×
boston blog main
boston top stories
life sciences
national blog main
5
×
national top stories
new york blog main
boston
fda
national
new york top stories
rna interference
san diego blog main
san diego top stories
san francisco blog main
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
gene therapy
harvard pilgrim health care
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
institute for clinical and economic review
patisiran
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
gene
5
×
drug
therapy
aren’t
bio
disease
fda
interference
medicines
protein
rna
roundup
advanced
alnylam
alnylam’s
approval
approves
bff
car
caught
causing
cells
conference
cutting
deals
developers
devoted
dicerna
drugs
easl
edge
ema
employ
europe
experiments
eye
follows
form
harmful
help
Language
unset
Current search:
" national blog main "
×
gene
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”